Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-03

FDA Approved: EDETATE CALCIUM DISODIUM — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for edetate calcium disodium (a chelating agent) from Rising Pharma Holdings, Inc., intended for treatment of lead poisoni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edetate calcium disodium (calcium disodium edetate)

Snippet

ORIG AP for EDETATE CALCIUM DISODIUM (EDETATE CALCIUM DISODIUM)